Home - Clinical Trials Arena
WEBPerimeter completes enrolment for AI-assisted breast imaging trial. The primary endpoint results from the trial are expected by the end of the year and will be used to support an FDA approval for the OCT B-Series device.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic.
Clinion EDC: Redefining clinical trials through AI
WEBClinion won the Innovation award for integrating artificial intelligence (AI) and machine learning (ML) into its electronic data capture (EDC) platform, significantly enhancing efficiency and data quality in clinical trials.
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · With an estimated market value of $37.1bn in 2031, the race for the development of obesity medications is on. Here are some trials to watch.
Hepatitis B: Four trials to watch over the next 12 months
WEBJul 28, 2023 · While Dr Antonio Bertoletti, professor at the Duke-NUS Medical School in Singapore and an infectious disease doctor who has been working on Hepatitis B trials for 30 years, said he thinks that it is more important for trials in Hepatitis B to find patient populations in which they may be most effective rather than seek a …
Top Ongoing mRNA Herpes Vaccine Trials - Clinical Trials Arena
WEBFeb 2, 2023 · Although most early clinical research into mRNA vaccines was dominated by institutions and government agencies, the tables have quickly turned. “mRNA technology is new and successful, and it looks like it’s going to be the next big breakthrough,” says Dr. Harvey Friedman, University of Pennsylvania, who is …
Rezdiffra for the Treatment of Noncirrhotic Non-alcoholic ...
WEBApr 2, 2024 · Rezdiffra (resmetirom) is a novel therapeutic indicated alongside diet and exercise for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis, corresponding to stages F2 to F3 fibrosis.
ProKidney amends Phase III protocol in light of Phase II results
WEBNov 14, 2023 · The Phase II interim data shows ProKidney’s autologous cell therapy React (rilparencel) has the potential to preserve kidney function in patients with moderate and high-risk diabetic chronic kidney disease (CKD).. In light of these results, the US-based company plans to update the protocol of its ongoing Phase III clinical trial REGEN-006 (NCT05099770).
Schizophrenia: Four major clinical trials to watch in 2023
WEBApr 13, 2023 · Phase III trials of Reviva Pharmaceuticals’s brilaroxazine, Newron Pharmaceuticals’s evenamide, and Sunovion Pharmaceuticals’s ulotaront are each targeting total symptoms of schizophrenia. Meanwhile, Acadia Pharmaceuticals’s pimavanserin focuses on the negative symptoms of schizophrenia, which include apathy, withdrawal, and blunted effect. ...
Eli Lilly's mirikizumab shows promise in Crohn's disease trial
WEBMay 22, 2024 · Eli Lilly has reported promising results from the Phase III VIVID-1 study of mirikizumab in treating moderately to severely active Crohn’s disease.
- Some results have been removed